IRADIMED CORPORATION

NasdaqGM:IRMD Stock Report

Market Cap: US$660.0m

IRADIMED Balance Sheet Health

Financial Health criteria checks 6/6

IRADIMED has a total shareholder equity of $83.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $94.2M and $10.8M respectively. IRADIMED's EBIT is $21.3M making its interest coverage ratio -11.4. It has cash and short-term investments of $51.7M.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ratio-11.4x
CashUS$51.72m
EquityUS$83.43m
Total liabilitiesUS$10.81m
Total assetsUS$94.25m

Recent financial health updates

No updates

Recent updates

IRADIMED's (NASDAQ:IRMD) Solid Profits Have Weak Fundamentals

Aug 08
IRADIMED's (NASDAQ:IRMD) Solid Profits Have Weak Fundamentals

If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity

Feb 23
If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity

Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely

Feb 07
Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely

Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?

Nov 06
Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?

Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)

Oct 13
Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)

At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?

Feb 05
At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?

Iradimed withdraws FDA filing for new infusion pump; prelim Q3 revenue rises 13% Y/Y

Oct 10

IRadimed: Record Revenue Could Translate To Share Price Appreciation

Aug 23

Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching

Aug 17
Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching

iRadimed Non-GAAP EPS of $0.26 beats by $0.02, revenue of $12.7M beats by $0.06M

Jul 29

IRadimed: Reduce Equity Beta With Upside Capture

Jul 18

IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively

Jul 13
IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively

At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?

Feb 05
At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?

Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital

Jan 12
Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital

Financial Position Analysis

Short Term Liabilities: IRMD's short term assets ($74.3M) exceed its short term liabilities ($8.1M).

Long Term Liabilities: IRMD's short term assets ($74.3M) exceed its long term liabilities ($2.8M).


Debt to Equity History and Analysis

Debt Level: IRMD is debt free.

Reducing Debt: IRMD had no debt 5 years ago.

Debt Coverage: IRMD has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: IRMD has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies